1. Home
  2. ALT vs AWP Comparison

ALT vs AWP Comparison

Compare ALT & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • AWP
  • Stock Information
  • Founded
  • ALT 1997
  • AWP 2007
  • Country
  • ALT United States
  • AWP United States
  • Employees
  • ALT N/A
  • AWP N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • AWP Trusts Except Educational Religious and Charitable
  • Sector
  • ALT Health Care
  • AWP Finance
  • Exchange
  • ALT Nasdaq
  • AWP Nasdaq
  • Market Cap
  • ALT 292.0M
  • AWP 346.7M
  • IPO Year
  • ALT N/A
  • AWP N/A
  • Fundamental
  • Price
  • ALT $3.83
  • AWP $3.99
  • Analyst Decision
  • ALT Strong Buy
  • AWP
  • Analyst Count
  • ALT 6
  • AWP 0
  • Target Price
  • ALT $17.40
  • AWP N/A
  • AVG Volume (30 Days)
  • ALT 3.0M
  • AWP 331.5K
  • Earning Date
  • ALT 08-12-2025
  • AWP 01-01-0001
  • Dividend Yield
  • ALT N/A
  • AWP 12.48%
  • EPS Growth
  • ALT N/A
  • AWP N/A
  • EPS
  • ALT N/A
  • AWP N/A
  • Revenue
  • ALT $20,000.00
  • AWP N/A
  • Revenue This Year
  • ALT N/A
  • AWP N/A
  • Revenue Next Year
  • ALT $761,880.20
  • AWP N/A
  • P/E Ratio
  • ALT N/A
  • AWP N/A
  • Revenue Growth
  • ALT N/A
  • AWP N/A
  • 52 Week Low
  • ALT $2.90
  • AWP $3.06
  • 52 Week High
  • ALT $11.16
  • AWP $4.20
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • AWP 63.22
  • Support Level
  • ALT $3.35
  • AWP $3.95
  • Resistance Level
  • ALT $3.66
  • AWP $4.01
  • Average True Range (ATR)
  • ALT 0.19
  • AWP 0.04
  • MACD
  • ALT 0.07
  • AWP 0.01
  • Stochastic Oscillator
  • ALT 86.18
  • AWP 85.71

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About AWP abrdn Global Premier Properties Fund of Beneficial Interest

Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.

Share on Social Networks: